Closing the translation gap in oncology drug development
Drug Discovery World
MAY 9, 2023
The recent passage of the FDA Modernization Act, which removed the requirement for animal testing when suitable alternatives are available, has highlighted the inadequacy of animal models most often used for in vivo research. Fewer than 5% of oncology drugs that enter clinical trials in the US receive US FDA approval.
52 
Let's personalize your content